全球布鲁氏菌病疫苗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球布鲁氏菌病疫苗市场需求预计将从 2023 年的 27,938 万美元达到 2032 年近 4,4,128 万美元的市场规模，2024-2032 年研究期间复合年增长率为 5.21%。

布鲁氏菌病也称为马耳他热、波浪热、地中海热，是由受感染动物的未煮熟的肉或摄入未经高温消毒的牛奶或与其分泌物密切接触而引起的感染。布鲁氏菌病疫苗适用于牛、绵羊和山羊。目前，尚无适用于人类的疫苗。疫苗接种的作用是产生免疫反应，增强动物对疾病的抵抗力，对于控制、管理和消除布鲁氏菌病很重要。

市场动态

畜牧业生产的成长和动物传播传染病的威胁正在推动市场的成长。随着畜牧业的持续成长和转型，粮食安全和人类营养面临巨大的挑战。受牛奶、肉类和鸡蛋消费量增加的影响，对畜产品的需求日益增长。在全球范围内，布鲁氏菌病被认为是最常见的人畜共通传染病，每年记录的病例超过 50 万例。市场的成长得到了疫苗接种计划的支持。另一方面，许多地区无法提供有效的诊断或治疗，或没有充分执行检测和预防人类和动物感染的计画。这些地区需要政府兽医和卫生部门之间的协调与合作，以帮助预防和控制布鲁氏菌病。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球布鲁氏菌病疫苗市场的每个细分市场进行了包容性评估。布鲁氏菌病疫苗产业的成长和趋势为本研究提供了整体方法。

市场区隔

布鲁氏菌病疫苗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

• 次单位疫苗（重组疫苗、结合疫苗、类毒素疫苗）
• 灭活
• 活衰减
• mRNA腺病毒
• 病毒载体疫苗

依给药途径

• 口服
• 注射用
• 鼻腔

按疾病适应症

• 病毒性疾病（肝炎、流感、HPV、MMR、轮状病毒、带状疱疹、Covid-19 等）
• 细菌疫苗（脑膜炎双球菌病、肺炎球菌病、百白破、其他）
• 癌症疫苗
• 过敏疫苗

按年龄

• 儿科
• 成人

按配销通路

• 医院和零售药房
• 政府供应商
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲布鲁氏菌病疫苗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。布鲁氏菌病疫苗市场的主要参与者包括 Merck & Co. Inc.、Laboratories Tornel、Hester Biosciences Limited、Ceva、CZ Vaccines。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：布鲁氏菌病疫苗 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 按给药途径进行的市场吸引力分析
  • 依疾病适应症进行的市场吸引力分析
  • 按年龄分類的市场吸引力分析
  • 按配销通路分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球布鲁氏菌病疫苗市场分析：按类型

• 按类型概述
• 按类型分析历史和预测数据
• 次单位疫苗（重组疫苗、结合疫苗、类毒素疫苗）
• 灭活
• 活衰减
• mRNA腺病毒
• 病毒载体疫苗

第 6 章：全球布鲁氏菌病疫苗市场分析：依给药途径

• 依给药途径概述
• 按给药途径进行历史和预测资料分析
• 口服
• 注射用
• 鼻腔

第 7 章：全球布鲁氏菌病疫苗市场分析：依疾病适应症

• 按疾病适应症概述
• 按疾病迹象进行历史和预测数据分析
• 病毒性疾病（肝炎、流感、HPV、MMR、轮状病毒、带状疱疹、Covid-19 等）
• 细菌疫苗（脑膜炎双球菌病、肺炎球菌病、百白破、其他）
• 癌症疫苗
• 过敏疫苗

第 8 章：全球布鲁氏菌病疫苗市场分析：依年龄分类

• 按年龄划分概述
• 按年龄分类的历史和预测资料分析
• 儿科
• 成人

第 9 章：全球布鲁氏菌病疫苗市场分析：按分销管道

• 配销通路概览
• 按配销通路进行历史和预测资料分析
• 医院和零售药房
• 政府供应商
• 其他的

第 10 章：全球布鲁氏菌病疫苗市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 11 章：布鲁氏菌病疫苗公司的竞争格局

• 布鲁氏菌病疫苗市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 12 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Merck & Co. Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Laboratories Tornel
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hester Biosciences Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Ceva
• 公司概况
• 公司收入
• 产品
• 最新动态
• CZ Vaccines
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Brucellosis Vaccines Market is presumed to reach the market size of nearly USD 441.28 Million by 2032 from USD 279.38 Million in 2023 with a CAGR of 5.21% under the study period 2024-2032.

Brucellosis also is known as malta fever, undulant fever, Mediterranean fever, is an infection caused by undercooked meat of infected animals or ingestion of unpasteurized milk or close contact with their secretion. Brucellosis vaccine is meant for cattle, sheep and goats. Currently, there is no vaccine available for humans. Vaccination works by producing an immune response that increases the animal's resistance to the diseases and is important to control, manage and eliminate brucellosis.

MARKET DYNAMICS

Growing livestock production and the threat of animal-borne infectious diseases are driving the growth of the market. With continuous growth and transformation of the livestock sector offer substantial challenges associated with food security and human nutrition. Demand for livestock products is growing influenced by increasing consumption of milk, meat, and eggs. Globally, brucellosis is considered as the most common zoonotic disease, with more than 500,000 cases recorded annually. Growth of the market is backed by a vaccination programme. On the other hand, there are many regions where effective diagnosis or treatment is not available or where programmes for the detection and prevention of the infection in humans and animals are not adequately carried out. Such regions need co-ordination and collaboration between veterinary and health sectors of government to help prevent and control brucellosis.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Brucellosis Vaccines. The growth and trends of Brucellosis Vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Brucellosis Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines)
• Inactivated
• Live Attenuated
• mRNA Aaccines
• Viral Vector Vaccines

By Route of Administration

• Oral
• Parenteral
• Nasal

By Disease Indication

• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
• Cancer Vaccines
• Allergy Vaccines

By Age

• Pediatric
• Adult

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Brucellosis Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brucellosis Vaccines market include Merck & Co. Inc., Laboratories Tornel, Hester Biosciences Limited, Ceva, CZ Vaccines. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BRUCELLOSIS VACCINES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Route of Administration
  • 3.7.3 Market Attractiveness Analysis By Disease Indication
  • 3.7.4 Market Attractiveness Analysis By Age
  • 3.7.5 Market Attractiveness Analysis By Distribution Channel
  • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Historic and Forecast Sales By Regions
• 5.4. Inactivated Historic and Forecast Sales By Regions
• 5.5. Live Attenuated Historic and Forecast Sales By Regions
• 5.6. mRNA Aaccines Historic and Forecast Sales By Regions
• 5.7. Viral Vector Vaccines Historic and Forecast Sales By Regions

6. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 6.1. Overview By Route of Administration
• 6.2. Historical and Forecast Data Analysis By Route of Administration
• 6.3. Oral Historic and Forecast Sales By Regions
• 6.4. Parenteral Historic and Forecast Sales By Regions
• 6.5. Nasal Historic and Forecast Sales By Regions

7. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY DISEASE INDICATION

• 7.1. Overview By Disease Indication
• 7.2. Historical and Forecast Data Analysis By Disease Indication
• 7.3. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
• 7.4. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
• 7.5. Cancer Vaccines Historic and Forecast Sales By Regions
• 7.6. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY AGE

• 8.1. Overview By Age
• 8.2. Historical and Forecast Data Analysis By Age
• 8.3. Pediatric Historic and Forecast Sales By Regions
• 8.4. Adult Historic and Forecast Sales By Regions

9. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 9.1. Overview By Distribution Channel
• 9.2. Historical and Forecast Data Analysis By Distribution Channel
• 9.3. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
• 9.4. Government Suppliers Historic and Forecast Sales By Regions
• 9.5. Others Historic and Forecast Sales By Regions

10. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE BRUCELLOSIS VACCINES COMPANIES

• 11.1. Brucellosis Vaccines Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF BRUCELLOSIS VACCINES INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Merck & Co. Inc.
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. Laboratories Tornel
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. Hester Biosciences Limited
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Ceva
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. CZ Vaccines
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Type (USD MN)
• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Market Sales By Geography (USD MN)
• Inactivated Market Sales By Geography (USD MN)
• Live Attenuated Market Sales By Geography (USD MN)
• mRNA Aaccines Market Sales By Geography (USD MN)
• Viral Vector Vaccines Market Sales By Geography (USD MN)
• Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Nasal Market Sales By Geography (USD MN)
• Analysis By Disease Indication (USD MN)
• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
• Cancer Vaccines Market Sales By Geography (USD MN)
• Allergy Vaccines Market Sales By Geography (USD MN)
• Analysis By Age (USD MN)
• Pediatric Market Sales By Geography (USD MN)
• Adult Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
• Government Suppliers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Brucellosis Vaccines Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Brucellosis Vaccines Report
• Market Research Process
• Market Research Methodology
• Global Brucellosis Vaccines Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Type
• Market Attractiveness Analysis By Route of Administration
• Market Attractiveness Analysis By Disease Indication
• Market Attractiveness Analysis By Age
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Type (USD MN)
• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Market Sales By Geography (USD MN)
• Inactivated Market Sales By Geography (USD MN)
• Live Attenuated Market Sales By Geography (USD MN)
• mRNA Aaccines Market Sales By Geography (USD MN)
• Viral Vector Vaccines Market Sales By Geography (USD MN)
• Global Market Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Nasal Market Sales By Geography (USD MN)
• Global Market Analysis By Disease Indication (USD MN)
• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
• Cancer Vaccines Market Sales By Geography (USD MN)
• Allergy Vaccines Market Sales By Geography (USD MN)
• Global Market Analysis By Age (USD MN)
• Pediatric Market Sales By Geography (USD MN)
• Adult Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
• Government Suppliers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.